BNET Industries

Market Cap:$174.8K
Last Fiscal Year Sales:$49.7K
  • Public
  • US
Dow Jones Description

We are an early-stage company established for the purpose of commercializing, marketing and selling over-the-counter, or OTC, pharmaceutical products that we believe incorporate topical and transdermal formulation platforms. We began our operations in January 2001, as a division of BioChemics, a biopharmaceutical company engaged in the development of transdermal and topical drug delivery systems. BioChemics is based in Danvers, Massachusetts. BioChemics was founded in 1989 by John J. Masiz and was incorporated in Delaware in 1991. By virtue of his ownership of BioChemics and Vaso Active, Mr. Masiz controls both BioChemics and Vaso Active. BioChemics began developing the VALE technology in 1989 and has subsequently been issued 4 U.S. patents in connection with this technology. We are also based in Danvers, Massachusetts. In January 2003, we incorporated in Delaware and became an independent subsidiary of BioChemics, focused on the further commercialization of our existing OTC products and the development of new OTC product candidates.

Acting President & CEO
Joseph Frattaroli
Number of Employees 5
Contact Information

99 Rosewood Dr Ste 260

Danvers, Massachusetts 01923

www.vasoactive....

(978) 750-1991

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

vaso active pharmaceuticals inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Joseph Frattaroli Acting President & CEO
Stephen G. Carter Vice President & Chief Scientific Officer
Stephen Cataldo Director, Marketing
Elizabeth Russo Controller

Board of Directors

Name (plus bio) Position
Robert E. Anderson Chair of Board
Brian J. Strasnick Board of Directors
Bruce A. Shear Board of Directors
D'Anne Hurd Board of Directors
Ronald Guerriero Board of Directors

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Acting President & CEO Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Vice President & Chief Scientific Officer Current
Vaso Active Pharmaceuticals, Inc. Board of Directors Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Director, Marketing Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Controller Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Chair of Board Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Board of Directors Current

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Board of Directors Current

Ms. D Anne Hurd has been a Director of the Company since October 2006. Ms. Hurd currently serves as Vice President and General Counsel for Worcester Polytechnic Institute (WPI) and Vice President for Business Development at Gateway Park (WPI s life sciences/ bioengineering development). She has held these positions since January 2006. Ms. Hurd is Chairman of the Audit Committee of Data Translation, Inc. (DATX) and Vaso Active Pharmaceuticals, Inc. (VAPH). She brings over 30 years of experience in start-ups as well as established public companies, most recently serving as Senior Vice President, CFO and Treasurer of NMS Communications, Inc. (NMSS). Ms. Hurd served as CFO and General Counsel of STARBAK Communications, Inc. and its predecessor company, Vividon, Inc. from March 2001 until January 2004. Prior to joining Vividon, Inc., Ms. Hurd served as CFO and General Counsel for NaviPath, Inc., a majority-owned subsidiary of CMGI, Inc. Previously, Ms. Hurd was the CFO and General Counsel for SmartRoute Systems, Inc., the Cambridge, MA provider of real-time, digital traffic data. Ms. Hurd s years of experience in executive-level management also includes senior finance positions at GTE Corporation and PepsiCo, Inc. where she was responsible for their global cash management and banking relationships, and seven years as an associate with the Boston law firm Burns & Levinson, where she advised private and public clients on all aspects of corporate finance and securities law. Ms. Hurd also serves on the Board of Directors of the New England Chapter of the National Association of Corporate Directors (NACD) as well as several other nonprofit entities. During the Company s fiscal year ended March 31, 2008 ( Fiscal 2008 ), the Board of Directors held eight meetings and acted twice by unanimous written consent. During Fiscal 2008, each director attended each meeting. All of the Board members attended the Company s 2007 Annual Meeting of Stockholders either in person or telephonically, and the Company expects that all of the Board members will attend the 2008 Annual Meeting.

Organization Position Status
Gateway Park LLC Vice President for Business Development Current
National Association of Corporate Directors Board of Directors Current
Micronetics Inc. Board of Directors Current
Vaso Active Pharmaceuticals, Inc. Board of Directors Current
Smartroute Systems, Inc. Cfo Former
Smartroute Systems, Inc. General Counsel Former
Vividon Former

Organization Position Status
Vaso Active Pharmaceuticals, Inc. Board of Directors Current
advertisement
     VAPH $0.03 0.00 (0.00% )
Average Volume 5,081
Shares Outstanding 10.33M
Market Cap 309.9K
Year High 0.15
Year Low 0.02
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement